Problems of Radiation Medicine and Radiobiology

N. I. Bilous, I. V. Abramenko, A. A. Chumak, I. S. Diagil, Z. V. Martina

State Institution «National Research Center for Radiation Medicine of the National Academy of Medical
Sciences of Ukraine», 53 Yuriia Illienka St., Kyiv, 04050, Ukraine

EXPRESSION OF LIPOPROTEIN LIPASE AND c-MYC ONCOGENE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AFFECTED BY THE CHORNOBYL ACCIDENT

Objective. to determine the association between the expression of lipoprotein lipase (LPL) and c-MYC genes in peripheral blood cells of chronic lymphocytic leukemia (CLL) patients affected by the Chornobyl catastrophe depending on the mutational status of IGHV genes.
Methods. Analysis was performed in the group of 69 CLL patients irradiated due to the Chornobyl NPP accident (58 clean-up workers of 1986 year, 6 inhabitants of radionuclide contaminated areas, and 5 evacuees). The IGHV gene mutational status was studied by polymerase chain reaction (PCR) followed by direct sequencing. LPL and c-MYC expression was evaluated by Quantitative Real-time PCR. Data were analyzed with the SPSS software package, version 20.0.
Results. Relative LPL expression levels in CLL samples ranged from 0 to 1663.5 (mean 138.47 ± 30.69, median 26.1). A strong correlation between individual LPL expression levels and IGHV mutational status was found (r = 0.684; p < 0.0001). The average relative c-MYC expression level was 5.7 ± 0.87 (median 2.86; range 0–48.5). No association between c-MYC expression and IGHV mutational status was found. Among unmutated IGHV cases, a correlation between LPL and c-MYC gene expression levels was identified: r = 0.351; p = 0.013.
Conclusions. Our data confirm the dominant concept that unmutated IGHV CLL cases are more sensitive to the action of proliferative stimuli compared to mutated IGHV CLL cases. This is manifested by an increase in the expression of a functionally significant LPL gene, is one for the strongest negative prognostic markers in CLL.
Key words: lymphocytic leukemia, LPL, c-MYC, IGHV genes, Chornobyl NPP accident.

Problems of Radiation Medicine and Radiobiology.
2020;25:421-429. doi: 10.33145/2304-8336-2020-25-421-429

full text

1. Romanenko A, Finch S, Hatch M, Lubin JH, Bebeshko VG, Bazyka DA, et al. The Ukrainian-American study of leukemia and related disorders among Chornobyl cleanup workers from Ukraine: III. Radiation risks. Radiat Res. 2008;170(6):711-720. URL: https://doi: 10.1667/RR1404.1.
2. Zablotska LB, Bazyka D, Lubin JH, Gudzenko N, Little MP, Hatch M, et al. Radiation and the risk of chronic lymphocytic and other leukemias among Chornobyl clean-up workers. Environ Health Perspect. 2013;121(1):59-65. doi: 10.1289/ehp.1204996.
3. Bazyka D, Gudzenko N, Dyagil I, Ilienko I, Belyi D, Chumak V, et al. Cancers after Chornobyl: from epidemiology to molecular quantification. Cancers (Basel). 2019 Sep;11(9). pii E1291. doi: 10.3390/cancers11091291.
4. Gluzman DF, Sklyarenko LM, Nadgornaya VA, Zavelevich MP. Mature B-cell neoplasms in Chernobyl clean-up workers of 1986–1987: summary of cytomorphological and immunocytochemical study in 25 years after Chernobyl accident. Exp Oncol. 2011;33(1):47-51.
5. Hamblin TJ, Davis Z, Garddiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94(6):1848-1854.
6. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94(6):1840-1847.
7. Zalcberg I, D’Andrea MG, Monteiro L, Pimenta G, Xisto B. Multidisciplinary diagnostics of chronic lymphocytic leukemia: European Research Initiative on CLL - ERIC recommendations. Hematol Transfus Cell Ther. 2019 Sep. pii: S2531-1379(19)30132-4. doi: 10.1016/j.htct.2019.07.006.
8. Rozovski U, Keating MJ, Estrov Z. Why is the immunoglobulin heavy chain gene mutation status a prognostic indicator in chronic lymphocytic leukemia? Acta Haematol. 2018;140(1):51-54. doi: 10.1159/000491382.
9. Klein U, Tu Y, Stolovitzky GA, Mattioli M, Cattoretti G, Husson H, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 2001;194(11):1625-1638. doi: 10.1084/jem.194.11.1625.
10. Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 2001;194(11):1639-1647. doi: 10.1084/jem.194.11.1639.
11. Vasconcelos Y, De Vos J, Vallat L, Reme T, Lalanne AI, Wanherdrick K, et al. Gene expression profiling of chronic lymphocytic leukemia can discriminate cases with stable disease and mutated Ig genes from those with progressive disease and unmutated Ig genes. Leukemia. 2005;19(11):2002-2005. doi: 10.1038/sj.leu.2403865.
12. Prieto D, Oppezzo P. Lipoprotein lipase expression in chronic lymphocytic leukemia: new insights into leukemic progression. Molecules. 2017;22(12):2083. doi: 10.3390/molecules22122083.
13. Hartman ML, Kilianska ZM. Lipoprotein lipase: a new prognostic factor in chronic lymphocytic leukaemia. Contemp Oncol (Pozn). 2012;16(6):474-479. doi: 10.5114/wo.2012.32476.
14. Tesi A, de Pretis S, Furlan M, Filipuzzi M, Morelli MJ, Andronache A, et al. An early Myc-dependent transcriptional program orchestrates cell growth during B-cell activation. EMBO Rep. 2019;20(9):e47987. doi: 10.15252/embr.201947987.
15. Abramenko I, Bilous N, Chumak A, Davidova E, Kryachok I, Martina Z, et al. Chronic lymphocytic leukemia patients exposed to ionizing radiation due to the Chernobyl NPP accident – with focus on immunoglobulin heavy chain gene analysis. Leuk Res. 2008;32(4):535-545. URL: https://doi.org/10.1016/j.leukres.2007.08.013.
16. Lefranc M-P, Lefranc G. IMGT® and 30 years of immunoinformatics insight in antibody V and C domain structure and function. Antibodies (Basel). 2019;8(2):29. doi: 10.3390/antib8020029.
17. Caraballo JM, Acosta JC, Cortes MA, Albajar M, Gomez-Casares MT, Batlle-Lopez A, et al. High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycle. Oncotarget. 2014;5(13):4694-4708.
18. van Bockstaele F, Pede V, Janssens A, Callewaert F, Offner F, Verhasselt B, Phillippe J. Lipoprotein lipase mRNA expression in whole blood is a prognostic marker in B cell chronic lymphocytic leukemia. Clin Chem. 2007;53(2):204-212.
19. Beillard E, Pallisgaard N, van der Velden VH, Bi W, Dee R, van der Schoot E, et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program. Leukemia. 2003;17(12):2474-2486.
20. Weaver S, Dube S, Mir A, Qin J. Ramakrishnan R, Jones RC, Livak KJ. Taking qPCR to a higher level: Analysis of CNV reveals the power of high throughput qPCR to enhance quantitative resolution. Methods. 2010;50(4):271-276. doi: 10.1016/j.ymeth.2010.01.003.
21. Stasik CJ, Nitta H, Zhang W, Mosher CH, Cook JR, Tubbs RR, et al. Increased MYC gene copy number correlates with increased mRNA levels in diffyse large B-cell lymphoma. Haematologica. 2010;95(4):597-603. doi: 10.3324/haematol.2009.012864.
22. Kristensen L, Kristensen T, Abildgeerd N, Royo C, Frederiksen M, Mourits-Andersen T, et al. LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations. Eur J Haematol. 2016;97(2):175-182. doi: 10.1111/ejh.12700.
23. Antosz H, Paterski A, Marzec-Kotarska B, Sajewicz J, Dmoszynska A. Alterations in TP53, cyclin D2, c-Myc, p21WAF1/CIP1 and p27KIP1 expression associated with progression in B-CLL. Folia Histochem Cytobiol. 2010;48(4):534-541. doi: 10.2478/v10042-010-0048-5.
24. Brieghel C, da Cunha-Bang C, Yde CW, Schmidt AY, Kinalis S, Nadeu F, et al. The number of signaling pathways altered by driver mutations in chronic lymphocytic leukemia impacts disease outcome. Clin Cancer Res. 2020;26(6):1507-1515. doi: 10.1158/1078-0432.CCR-18-4158.
25. Rombout A, Lust S, Offner F, Naessens E, Verhasselt B, Philippe J. Mimicking the tumour microenvironment of chronic lymphocytic leukaemia in vitro critically depends on the type of B-cell receptor stimulation. Eur J Cancer. 2016;114(6):704-712. doi: 10.1038/bjc.2016.35.
26. Abreu C, Moreno P, Palacios F, Borge M, Morande P, Landoni AI, et al. Methylation status regulates lipoprotein lipase expression in chronic lymphocytic leukemia. Leuk Lymphoma. 2013;54(8):1844-1848. doi: 10.3109/10428194.2013.796057.